Close

Sign in
Sign up

Menu

Data Search
Content
Startup Concierge
Newsletters
Get intel

Home
News
ProVerum raised $80m in a B round led by MVM Partners, joined by OrbiMed, Ireland Strategic Investment Fund, Gilde, Lightstone Ventures, Atlantic Bridge

ProVerum raised $80m in a B round led by MVM Partners, joined by OrbiMed, Ireland Strategic Investment Fund, Gilde, Lightstone Ventures, Atlantic Bridge

Health services Manufacturing Pharma

United Kingdom

Ireland

Netherlands

United States

Investments

10 August 2025

Share:

Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!

ProVerum (company)

Ireland

Health services Manufacturing Pharma

Total investments received (USD): 113.99M

Round value (USD): 80M

Round investors: OrbiMed Advisors Lightstone Ventures Ireland Strategic Investment Fund Gilde Healthcare Atlantic Bridge Enterprise Ireland MVM Life Science Partners

Company: ProVerum

Industry: Health services Manufacturing Pharma

Related deals

Lattice Medical raised €43 million Series B funding round led by Bpifrance SPI, followed by Blast.club, Sprim, EIC Fund, Captech Santé, Nord France Amorçage

Health services Manufacturing

France

Belgium

Singapore

Investments 12 October 2025

Elevara Medicines raised $70m in Series A funding led by Forbion and Sofinnova Partners, joined by insiders Monograph Capital and Weatherden.

Health services Pharma

France

United Kingdom

Netherlands

Investments 02 October 2025

Trogenix raised €80m in Series A led by IQ Capital, joined by 4Bio, Cancer Research Horizons, Brain Tumour Fund, Eli Lilly, Meltwind, LongeVC and Calculus

Biotech Health services Manufacturing Pharma Software Services

United Kingdom

United States

Latvia

Investments 01 October 2025

MRM Health in a €55 million Series B financing round led by Biocodex, joined by Athos, BNP Paribas Fortis Private Equity, SFPIM, AvH, OMX, Qbic, VIB

Health services Pharma

Germany

France

United States

Belgium

Investments 01 September 2025

NRG Therapeutics closed a £50 million Series B funding round w/ British Business Bank, SV Health, M Ventures, Novartis, Criteria Bio Ventures, Omega Funds

Biotech Health services Pharma

Spain

Switzerland

United Kingdom

Netherlands

United States

Australia

Investments 01 September 2025

Sidebar

Verticals

Financial Services
Food Industry
Education
E-commerce
Health services
Marketplace

Benelux

Belgium
Netherlands

DACH

Austria
Germany
Switzerland

Nordics and Baltics

Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden

Western Europe

France
Ireland
Italy
Portugal
Spain
United Kingdom

About
Contact
Terms of service
Privacy policy

© All rights reserved Nordic 9 2016-2025. Made with in Stockholm

Top